Vera Therapeutics executive sells over $228k in company stock

Published on 11 Apr 2024 on Investing.com

In a recent transaction, Joseph R. Young, the Senior Vice President of Finance and Chief Accounting...

Read the rest of the article

Start tracking your investments with Statfolio

On Saturday, Vera Therapeutics Inc. (NASDAQ:VERA) released data from its ORIGIN Phase 2b trial of...

Benzinga · via Yahoo Finance 28 Oct 2024

We recently compiled a list of the 10 Best Performing Small-Cap Stocks in 2024. In this article, ...

Insider Monkey · via Yahoo Finance 29 Sep 2024

We recently compiled a list of the 10 Best Mid-Cap Healthcare Stocks To Buy Now. In this article,...

Insider Monkey · via Yahoo Finance 19 Sep 2024

Key Insights Significantly high institutional ownership implies Vera Therapeutics' stock price is...

Simply Wall St. via Yahoo Finance 6 May 2024

Vera Therapeutics Inc (NASDAQ:VERA), a clinical-stage biotechnology company focused on developing...

GuruFocus.com via Yahoo Finance 12 Apr 2024

In a recent transaction, Joseph R. Young, the Senior Vice President of Finance and Chief Accounti...

Investing.com 11 Apr 2024

On Wednesday, Vertex Pharmaceuticals Incorporated VRTX agreed to acquire Alpine Immune Sciences I...

Benzinga 11 Apr 2024

Alpine Immune’s lead candidate is being evaluated as a potential treatment for IgA Nephropathy, o...

Market Watch 11 Apr 2024

(Bloomberg) -- Vertex Pharmaceuticals Inc. agreed to buy Alpine Immune Sciences Inc. for a total ...

Bloomberg via Yahoo Finance 11 Apr 2024

Key Insights Using the 2 Stage Free Cash Flow to Equity, Vera Therapeutics fair value estimate is...

Simply Wall St. via Yahoo Finance 11 Feb 2024